NCT05725200 2023-02-21
EVIDENT
Oslo University Hospital
Phase 2 Recruiting
Clinical Trials
4 trialsNCT01056601 2017-12-28
Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT01528501 2013-05-01
HDAC
Technical University of Munich
Phase 2 Terminated
NCT00690677 2012-01-18
Phase II Trial of LBH589 in Refractory Colorectal Cancer
Swedish Medical Center
Phase 2 Completed